2,654
edits
mNo edit summary |
No edit summary |
||
Line 19: | Line 19: | ||
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Fee Billing Procedures]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions]] | [[Internal Audit]] | [[Credit Hour Definition]] | [[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Fee Billing Procedures]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions]] | [[Internal Audit]] | [[Credit Hour Definition]] | ||
<br /><br />Revised Date: 08/25/17<br /> | <br /><br />Revised Date: 08/25/17<br /> | ||
Reviewed Date: 08/25/17 | Reviewed Date: 08/25/17<br /> | ||
<big>'''Business Associate Agreements and Addendum Procedures'''</big><br /> | <big>'''Business Associate Agreements and Addendum Procedures'''</big><br /> |